來源: MarketWatch ↗

Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

|

暫時無法翻譯，請重試。

來源報導重點

Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.

在 MarketWatch 閱讀原始報導 ↗

推薦市場

此報導未識別到特定資產；可瀏覽即時 USDT 參考交易對。

瀏覽市場 →

USDC/USDT

$1.0000

-0.02%

BTC/USDT

$86,907.76

+7.13%

ETH/USDT

$2,780.45

+5.52%

SOL/USDT

$118.72

+7.60%

XRP/USDT

$1.53

+8.60%